These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1992 related items for PubMed ID: 18157145

  • 1. A simplified system for generating oncolytic adenovirus vector carrying one or two transgenes.
    Hu ZB, Wu CT, Wang H, Zhang QW, Wang L, Wang RL, Lu ZZ, Wang LS.
    Cancer Gene Ther; 2008 Mar; 15(3):173-82. PubMed ID: 18157145
    [Abstract] [Full Text] [Related]

  • 2. Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect.
    Choi KJ, Kim JH, Lee YS, Kim J, Suh BS, Kim H, Cho S, Sohn JH, Kim GE, Yun CO.
    Gene Ther; 2006 Jul; 13(13):1010-20. PubMed ID: 16525479
    [Abstract] [Full Text] [Related]

  • 3. A three-plasmid system for construction of armed oncolytic adenovirus.
    Liu HY, Han BJ, Zhong YX, Lu ZZ.
    J Virol Methods; 2009 Dec; 162(1-2):8-13. PubMed ID: 19646479
    [Abstract] [Full Text] [Related]

  • 4. Linked tumor-selective virus replication and transgene expression from E3-containing oncolytic adenoviruses.
    Zhu M, Bristol JA, Xie Y, Mina M, Ji H, Forry-Schaudies S, Ennist DL.
    J Virol; 2005 May; 79(9):5455-65. PubMed ID: 15827160
    [Abstract] [Full Text] [Related]

  • 5. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo.
    Li B, Liu X, Fan J, Qi R, Bo L, Gu J, Qian Q, Qian C, Liu X.
    J Gene Med; 2006 Oct; 8(10):1232-42. PubMed ID: 16900558
    [Abstract] [Full Text] [Related]

  • 6. A novel triple-regulated oncolytic adenovirus carrying PDCD5 gene exerts potent antitumor efficacy on common human leukemic cell lines.
    Xie M, Niu JH, Chang Y, Qian QJ, Wu HP, Li LF, Zhang Y, Li JL, Huang XJ, Ruan GR.
    Apoptosis; 2009 Sep; 14(9):1086-94. PubMed ID: 19551515
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Conditionally replicative adenovirus vector carrying TRAIL gene for enhanced oncolysis of human hepatocellular carcinoma.
    Ye X, Lu Q, Zhao Y, Ren Z, Ren XW, Qiu QH, Tong Y, Liang M, Hu F, Chen HZ.
    Int J Mol Med; 2005 Dec; 16(6):1179-84. PubMed ID: 16273304
    [Abstract] [Full Text] [Related]

  • 9. Oncolytic adenovirus that overproduces ADP and replicates selectively in tumors due to hTERT promoter-regulated E4 gene expression.
    Kuppuswamy M, Spencer JF, Doronin K, Tollefson AE, Wold WS, Toth K.
    Gene Ther; 2005 Nov; 12(22):1608-17. PubMed ID: 16034456
    [Abstract] [Full Text] [Related]

  • 10. Gene-viral cancer therapy using dual-regulated oncolytic adenovirus with antiangiogenesis gene for increased efficacy.
    Su C, Na M, Chen J, Wang X, Liu Y, Wang W, Zhang Q, Li L, Long J, Liu X, Wu M, Fan X, Qian Q.
    Mol Cancer Res; 2008 Apr; 6(4):568-75. PubMed ID: 18344493
    [Abstract] [Full Text] [Related]

  • 11. [Treatment of hepatocellular carcinoma with a novel gene-viral therapeutic system CNHK300-murine endostatin].
    Li GC, Nie MM, Yang JM, Su CQ, Sun LC, Qian YZ, Sham J, Fang GE, Wu MC, Qian QJ.
    Zhonghua Yi Xue Za Zhi; 2004 Jun 02; 84(11):943-8. PubMed ID: 15329284
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Augmenting the antitumor effect of TRAIL by SOCS3 with double-regulated replicating oncolytic adenovirus in hepatocellular carcinoma.
    Wei RC, Cao X, Gui JH, Zhou XM, Zhong D, Yan QL, Huang WD, Qian QJ, Zhao FL, Liu XY.
    Hum Gene Ther; 2011 Sep 02; 22(9):1109-19. PubMed ID: 21361790
    [Abstract] [Full Text] [Related]

  • 15. [Tumor-selective replication, cytotoxicity and GM-CSF production of oncolytic recombinant adenovirus in KH901 injection].
    Shen FB, Chang JH, Yang C, Li J, Guo Y, Yi B, Li HX, Ye XF, Wang L.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan 02; 38(1):31-4. PubMed ID: 17294722
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Modulation of telomerase promoter tumor selectivity in the context of oncolytic adenoviruses.
    Bilsland AE, Merron A, Vassaux G, Keith WN.
    Cancer Res; 2007 Feb 01; 67(3):1299-307. PubMed ID: 17283167
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. CG0070, a conditionally replicating granulocyte macrophage colony-stimulating factor--armed oncolytic adenovirus for the treatment of bladder cancer.
    Ramesh N, Ge Y, Ennist DL, Zhu M, Mina M, Ganesh S, Reddy PS, Yu DC.
    Clin Cancer Res; 2006 Jan 01; 12(1):305-13. PubMed ID: 16397056
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 100.